Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow-band ultraviolet B

被引:208
作者
Novák, Z
Bónis, B
Baltás, E
Ocsovszki, I
Ignácz, F
Dobozy, A
Kemény, L
机构
[1] Univ Szeged, Dept Dermatol, H-6701 Szeged, Hungary
[2] Univ Szeged, Dept Biochem, H-6701 Szeged, Hungary
[3] Univ Szeged, Dept Opt & Quantum Elect, H-6701 Szeged, Hungary
基金
匈牙利科学研究基金会;
关键词
ultraviolet B; apoptosis; T cells; psoriasis;
D O I
10.1016/S1011-1344(02)00280-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Earlier we reported that a 308-nm xenon chloride (XeCl) UVB laser is highly effective for treating psoriasis. As ultraviolet B light seems to cause T cell apoptosis, in the present study we studied the ability of the XeCl laser to induce T-cell apoptosis in vitro, and then compared the apoptosis-inducing capacities of narrow-band UVB (NB-UVB) light and the XeCl laser. The role of laser impulse frequency and intensity in the therapeutical and apoptosis-inducing efficacy of XeCl laser was also investigated. Both XeCl laser and NB-UVB induced T cell apoptosis, but quantitative induction was greater with XeCl laser. Changes in the frequency and intensity of impulses of XeCl laser did not influence its therapeutic and T cell apoptosis-inducing efficacy. These results suggest that the more effective induction of T cell apoptosis can be responsible for the greater clinical efficacy of XeCl laser compared to NB-UVB. Additionally, the optical properties of the XeCl laser (a monochromatic, coherent, pulse-mode laser; easier precise dosimetry, there are no 'contaminating' wavelengths) can make this laser light an ideal tool for studies of the mode of action of UVB light. (C) 2002 Elsevier Science BY. All rights reserved.
引用
收藏
页码:32 / 38
页数:7
相关论文
共 15 条
[1]
THE OPTICS OF HUMAN-SKIN [J].
ANDERSON, RR ;
PARRISH, JA .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1981, 77 (01) :13-19
[2]
308-nm excimer laser for the treatment of psoriasis -: A dose-response study [J].
Asawanonda, P ;
Anderson, RR ;
Chang, YC ;
Taylor, CR .
ARCHIVES OF DERMATOLOGY, 2000, 136 (05) :619-624
[3]
Ashcroft DM, 1999, BRIT J DERMATOL, V141, P185
[4]
Repigmentation of localized vitiligo with the xenon chloride [J].
Baltás, E ;
Nagy, P ;
Bónis, B ;
Novák, Z ;
Ignácz, F ;
Szabó, G ;
Bor, Z ;
Dobozy, A ;
Kemény, L .
BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (06) :1266-1267
[5]
308 nm UVB excimer laser for psoriasis [J].
Bonis, B ;
Kemeny, L ;
Dobozy, A ;
Bor, Z ;
Szabo, G ;
Ignacz, F .
LANCET, 1997, 350 (9090) :1522-1522
[6]
Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B [J].
Coven, TR ;
Burack, LH ;
Gilleaudeau, P ;
Keogh, M ;
Ozawa, M ;
Krueger, JG .
ARCHIVES OF DERMATOLOGY, 1997, 133 (12) :1514-1522
[7]
FELDMAN SR, 2001, IN PRESS J AM ACAD D
[8]
Photobiology 102: UV sources and dosimetry - the proper use and measurement of "photons as a reagent" [J].
Gasparro, FP ;
Brown, DB .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (04) :613-615
[9]
IDENTIFICATION OF PROGRAMMED CELL-DEATH INSITU VIA SPECIFIC LABELING OF NUCLEAR-DNA FRAGMENTATION [J].
GAVRIELI, Y ;
SHERMAN, Y ;
BENSASSON, SA .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :493-501
[10]
CUMULATIVE EFFECTS FROM REPEATED EXPOSURES TO SUBERYTHEMAL DOSES OF UVB AND UVA IN HUMAN SKIN [J].
LAVKER, RM ;
GERBERICK, GF ;
VERES, D ;
IRWIN, CJ ;
KAIDBEY, KH .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 32 (01) :53-62